Study Shows that Existing Drug Class May Help Patients with Skin Cancer that Resists Standard Treatments
June 10, 2025
June 10, 2025
NEW YORK, June 10 [Category: BizHospital] -- NYU Langone Health, an academic medical center affiliated with New York University, posted the following news release:
* * *
Study Shows that Existing Drug Class May Help Patients with Skin Cancer that Resists Standard Treatments
*
I ncreased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not respond to the latest cancer treatments, a new . . .
* * *
Study Shows that Existing Drug Class May Help Patients with Skin Cancer that Resists Standard Treatments
*
I ncreased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not respond to the latest cancer treatments, a new . . .